clinical trial · NCT07425899
A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult Participants
AbbVie·phase1·recruiting·n = 32
Healthy VolunteerABBV-722Upadacitinib
brief summary
This is a Phase 1 study to investigate safety and pharmacokinetics of ABBV-722 and Upadacitinib following multiple oral doses in healthy adult participants.
started
Feb 26, 2026
primary completion
Aug 1, 2026
completion
Aug 1, 2026
last updated
Apr 17, 2026
official title
A Phase 1 Study to Evaluate the Pharmacokinetic Interaction and Safety of ABBV-722 and Upadacitinib Following Multiple Oral Doses in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol